Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Altimmune Inc have a median target of 24.00, with a high estimate of 28.00 and a low estimate of 10.00. The median estimate represents a 152.90% increase from the last price of 9.49.
High | 195.0% | 28.00 |
Med | 152.9% | 24.00 |
Low | 5.4% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +1.05% |
Average growth rate | -2.79% |
More ▼
Revenue history & estimates in USD
Average growth rate | -44.07% |
Average growth rate | -34.80% |
More ▼